Vir Biotechnology, Inc. (NASDAQ:VIR) has seen 1,065,058 shares traded in the last trading session. The company, currently valued at $6.22 Billion, closed the last trade at $49.23 per share which meant it lost -$1.4 on the day or -2.84% during that session. The VIR stock price is -52.35% off its 52-week high price of $75 and 76.34% above the 52-week low of $11.65. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.49 Million shares traded. The 3-month trading volume is 1.61 Million shares.
The consensus among analysts is that Vir Biotechnology, Inc. (VIR) is a Hold stock at the moment, with a recommendation rating of 3.2. 1 analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 5 have rated it as a Hold, with 2 advising it as a Buy. 1 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.62.
Vir Biotechnology, Inc. (NASDAQ:VIR) trade information
Despite being -2.84% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Jul 15 when the VIR stock price touched $52.31- or saw a rise of 5.89%. Year-to-date, Vir Biotechnology, Inc. shares have moved 291.49%, while the 5-day performance has seen it change 4.3%. Over the past 30 days, the shares of Vir Biotechnology, Inc. (NASDAQ:VIR) have changed 35.32%. Short interest in the company has seen 4.26 Million shares shorted with days to cover at 2.65.
Wall Street analysts have a consensus price target for the stock at $32.5, which means that the shares’ value could jump -33.98% from current levels. The projected low price target is $17 while the price target rests at a high of $44. In that case, then, we find that the current price level is -10.62% off the targeted high while a plunge would see the stock lose -65.47% from current levels.
Vir Biotechnology, Inc. (VIR) estimates and forecasts
Earnings growth for 2020 is a modest -443.3%.
Vir Biotechnology, Inc. (NASDAQ:VIR)’s Major holders
Insiders own 14.54% of the company shares, while shares held by institutions stand at 63.78% with a share float percentage of 74.63%. Investors are also buoyed by the number of investors in a company, with Vir Biotechnology, Inc. having a total of 83 institutions that hold shares in the company. The top two institutional holders are SB Investment Advisers (UK) LTD with over 22.62 Million shares worth more than $775.07 Million. As of March 30, 2020, SB Investment Advisers (UK) LTD held 19.18% of shares outstanding.
The other major institutional holder is Temasek Holdings (Private) Limited, with the holding of over 5.5 Million shares as of March 30, 2020. The firm’s total holdings are worth over $188.48 Million and represent 4.66% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Smallcap World Fund and AB Cap Fd.-AB Small Cap Growth Port. As of March 30, 2020, the former fund manager holds about 0.93% shares in the company for having 1094305 shares of worth $37.5 Million while later fund manager owns 259.67 Thousand shares of worth $7.92 Million as of April 29, 2020, which makes it owner of about 0.22% of company’s outstanding stock.